nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—ESR1—liver cancer	0.356	1	CbGaD
Ethinyl Estradiol—ABCB11—Doxorubicin—liver cancer	0.0711	0.226	CbGbCtD
Ethinyl Estradiol—ABCC2—Sorafenib—liver cancer	0.0616	0.196	CbGbCtD
Ethinyl Estradiol—CYP2B6—Sorafenib—liver cancer	0.0392	0.125	CbGbCtD
Ethinyl Estradiol—ABCC2—Doxorubicin—liver cancer	0.0374	0.119	CbGbCtD
Ethinyl Estradiol—SLC10A1—bile canaliculus—liver cancer	0.0339	0.244	CbGeAlD
Ethinyl Estradiol—ABCB11—bile canaliculus—liver cancer	0.0335	0.241	CbGeAlD
Ethinyl Estradiol—CYP2C8—Sorafenib—liver cancer	0.0297	0.0944	CbGbCtD
Ethinyl Estradiol—CYP2B6—Doxorubicin—liver cancer	0.0238	0.0756	CbGbCtD
Ethinyl Estradiol—ABCB1—Sorafenib—liver cancer	0.0201	0.0639	CbGbCtD
Ethinyl Estradiol—ABCC2—bile canaliculus—liver cancer	0.017	0.123	CbGeAlD
Ethinyl Estradiol—ABCB1—Doxorubicin—liver cancer	0.0122	0.0388	CbGbCtD
Ethinyl Estradiol—CYP3A4—Sorafenib—liver cancer	0.012	0.0383	CbGbCtD
Ethinyl Estradiol—SLC10A1—bile duct—liver cancer	0.0106	0.0763	CbGeAlD
Ethinyl Estradiol—ABCB11—bile duct—liver cancer	0.0105	0.0754	CbGeAlD
Ethinyl Estradiol—SLC10A1—bile—liver cancer	0.00813	0.0586	CbGeAlD
Ethinyl Estradiol—ABCB11—bile—liver cancer	0.00803	0.058	CbGeAlD
Ethinyl Estradiol—CYP3A4—Doxorubicin—liver cancer	0.0073	0.0232	CbGbCtD
Ethinyl Estradiol—ABCC2—bile duct—liver cancer	0.00532	0.0384	CbGeAlD
Ethinyl Estradiol—ABCC2—bile—liver cancer	0.00409	0.0295	CbGeAlD
Ethinyl Estradiol—Infarction—Sorafenib—liver cancer	0.00363	0.0498	CcSEcCtD
Ethinyl Estradiol—Embolism venous—Sorafenib—liver cancer	0.002	0.0274	CcSEcCtD
Ethinyl Estradiol—Embolism—Sorafenib—liver cancer	0.00157	0.0215	CcSEcCtD
Ethinyl Estradiol—AOX1—gall bladder—liver cancer	0.00145	0.0105	CbGeAlD
Ethinyl Estradiol—NR1I2—liver—liver cancer	0.00132	0.00955	CbGeAlD
Ethinyl Estradiol—Venous thromboembolism—Epirubicin—liver cancer	0.00127	0.0174	CcSEcCtD
Ethinyl Estradiol—Venous thromboembolism—Doxorubicin—liver cancer	0.00117	0.0161	CcSEcCtD
Ethinyl Estradiol—Blood pressure increased—Sorafenib—liver cancer	0.00101	0.0138	CcSEcCtD
Ethinyl Estradiol—Influenza like illness—Sorafenib—liver cancer	0.000979	0.0134	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Sorafenib—liver cancer	0.000912	0.0125	CcSEcCtD
Ethinyl Estradiol—Erythema nodosum—Epirubicin—liver cancer	0.000862	0.0118	CcSEcCtD
Ethinyl Estradiol—Eczema—Sorafenib—liver cancer	0.000815	0.0112	CcSEcCtD
Ethinyl Estradiol—Erythema nodosum—Doxorubicin—liver cancer	0.000797	0.0109	CcSEcCtD
Ethinyl Estradiol—Leukorrhea—Epirubicin—liver cancer	0.000795	0.0109	CcSEcCtD
Ethinyl Estradiol—Embolism venous—Epirubicin—liver cancer	0.000739	0.0101	CcSEcCtD
Ethinyl Estradiol—Leukorrhea—Doxorubicin—liver cancer	0.000735	0.0101	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Sorafenib—liver cancer	0.000732	0.01	CcSEcCtD
Ethinyl Estradiol—Mood swings—Sorafenib—liver cancer	0.000694	0.0095	CcSEcCtD
Ethinyl Estradiol—Embolism venous—Doxorubicin—liver cancer	0.000683	0.00937	CcSEcCtD
Ethinyl Estradiol—Local reaction—Epirubicin—liver cancer	0.000673	0.00923	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Sorafenib—liver cancer	0.000662	0.00907	CcSEcCtD
Ethinyl Estradiol—SLC10A1—liver—liver cancer	0.000662	0.00477	CbGeAlD
Ethinyl Estradiol—ESR1—embryo—liver cancer	0.000655	0.00472	CbGeAlD
Ethinyl Estradiol—ABCB11—liver—liver cancer	0.000654	0.00472	CbGeAlD
Ethinyl Estradiol—Local reaction—Doxorubicin—liver cancer	0.000623	0.00854	CcSEcCtD
Ethinyl Estradiol—Quinestrol—ESR1—liver cancer	0.000622	0.124	CrCbGaD
Ethinyl Estradiol—Enlargement abdomen—Epirubicin—liver cancer	0.00062	0.00849	CcSEcCtD
Ethinyl Estradiol—Pelvic pain—Epirubicin—liver cancer	0.000613	0.0084	CcSEcCtD
Ethinyl Estradiol—Vaginal discharge—Epirubicin—liver cancer	0.000613	0.0084	CcSEcCtD
Ethinyl Estradiol—Embolism—Epirubicin—liver cancer	0.000581	0.00796	CcSEcCtD
Ethinyl Estradiol—Enlargement abdomen—Doxorubicin—liver cancer	0.000573	0.00786	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Sorafenib—liver cancer	0.000572	0.00785	CcSEcCtD
Ethinyl Estradiol—Pelvic pain—Doxorubicin—liver cancer	0.000567	0.00777	CcSEcCtD
Ethinyl Estradiol—Vaginal discharge—Doxorubicin—liver cancer	0.000567	0.00777	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Sorafenib—liver cancer	0.000564	0.00773	CcSEcCtD
Ethinyl Estradiol—Infestation—Sorafenib—liver cancer	0.000564	0.00773	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Sorafenib—liver cancer	0.000556	0.00762	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Sorafenib—liver cancer	0.000553	0.00758	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Sorafenib—liver cancer	0.000553	0.00758	CcSEcCtD
Ethinyl Estradiol—Embolism—Doxorubicin—liver cancer	0.000537	0.00736	CcSEcCtD
Ethinyl Estradiol—Thrombosis—Epirubicin—liver cancer	0.000527	0.00722	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Sorafenib—liver cancer	0.000509	0.00698	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Sorafenib—liver cancer	0.000506	0.00694	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Sorafenib—liver cancer	0.0005	0.00685	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Sorafenib—liver cancer	0.000498	0.00682	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Sorafenib—liver cancer	0.000496	0.0068	CcSEcCtD
Ethinyl Estradiol—Thrombosis—Doxorubicin—liver cancer	0.000487	0.00668	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Sorafenib—liver cancer	0.000479	0.00656	CcSEcCtD
Ethinyl Estradiol—Mestranol—ESR1—liver cancer	0.000471	0.0941	CrCbGaD
Ethinyl Estradiol—Desogestrel—ESR1—liver cancer	0.000466	0.093	CrCbGaD
Ethinyl Estradiol—Angiopathy—Sorafenib—liver cancer	0.000459	0.0063	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Sorafenib—liver cancer	0.000457	0.00627	CcSEcCtD
Ethinyl Estradiol—Alopecia—Sorafenib—liver cancer	0.000448	0.00613	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Sorafenib—liver cancer	0.000444	0.00608	CcSEcCtD
Ethinyl Estradiol—ESR2—liver—liver cancer	0.000442	0.00319	CbGeAlD
Ethinyl Estradiol—Malnutrition—Sorafenib—liver cancer	0.000441	0.00604	CcSEcCtD
Ethinyl Estradiol—SHBG—liver—liver cancer	0.00043	0.0031	CbGeAlD
Ethinyl Estradiol—Breast pain—Epirubicin—liver cancer	0.000427	0.00585	CcSEcCtD
Ethinyl Estradiol—AOX1—liver—liver cancer	0.000425	0.00307	CbGeAlD
Ethinyl Estradiol—Amenorrhoea—Epirubicin—liver cancer	0.000424	0.00581	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Sorafenib—liver cancer	0.000424	0.00581	CcSEcCtD
Ethinyl Estradiol—Estriol—ESR1—liver cancer	0.000411	0.0821	CrCbGaD
Ethinyl Estradiol—Herpes simplex—Epirubicin—liver cancer	0.000404	0.00554	CcSEcCtD
Ethinyl Estradiol—Angioedema—Sorafenib—liver cancer	0.000403	0.00552	CcSEcCtD
Ethinyl Estradiol—Breast pain—Doxorubicin—liver cancer	0.000395	0.00542	CcSEcCtD
Ethinyl Estradiol—Amenorrhoea—Doxorubicin—liver cancer	0.000392	0.00538	CcSEcCtD
Ethinyl Estradiol—Cough—Sorafenib—liver cancer	0.000385	0.00527	CcSEcCtD
Ethinyl Estradiol—Estramustine—ESR1—liver cancer	0.000382	0.0763	CrCbGaD
Ethinyl Estradiol—Etonogestrel—ESR1—liver cancer	0.000377	0.0752	CrCbGaD
Ethinyl Estradiol—Herpes simplex—Doxorubicin—liver cancer	0.000374	0.00513	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000373	0.00511	CcSEcCtD
Ethinyl Estradiol—Vaginal inflammation—Epirubicin—liver cancer	0.000373	0.00511	CcSEcCtD
Ethinyl Estradiol—Cystitis noninfective—Epirubicin—liver cancer	0.000364	0.00499	CcSEcCtD
Ethinyl Estradiol—Influenza like illness—Epirubicin—liver cancer	0.000362	0.00496	CcSEcCtD
Ethinyl Estradiol—Cystitis—Epirubicin—liver cancer	0.00036	0.00493	CcSEcCtD
Ethinyl Estradiol—Infection—Sorafenib—liver cancer	0.000357	0.0049	CcSEcCtD
Ethinyl Estradiol—Fluid retention—Epirubicin—liver cancer	0.000354	0.00485	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Sorafenib—liver cancer	0.000353	0.00484	CcSEcCtD
Ethinyl Estradiol—Vaginal infection—Epirubicin—liver cancer	0.000352	0.00482	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Sorafenib—liver cancer	0.000349	0.00479	CcSEcCtD
Ethinyl Estradiol—Vaginal inflammation—Doxorubicin—liver cancer	0.000345	0.00473	CcSEcCtD
Ethinyl Estradiol—Bladder pain—Epirubicin—liver cancer	0.000337	0.00462	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Epirubicin—liver cancer	0.000337	0.00462	CcSEcCtD
Ethinyl Estradiol—Cystitis noninfective—Doxorubicin—liver cancer	0.000337	0.00462	CcSEcCtD
Ethinyl Estradiol—Influenza like illness—Doxorubicin—liver cancer	0.000335	0.00459	CcSEcCtD
Ethinyl Estradiol—Cystitis—Doxorubicin—liver cancer	0.000333	0.00456	CcSEcCtD
Ethinyl Estradiol—ABCC2—liver—liver cancer	0.000333	0.0024	CbGeAlD
Ethinyl Estradiol—Fluid retention—Doxorubicin—liver cancer	0.000327	0.00449	CcSEcCtD
Ethinyl Estradiol—Vaginal infection—Doxorubicin—liver cancer	0.000326	0.00446	CcSEcCtD
Ethinyl Estradiol—Estropipate—ESR1—liver cancer	0.000315	0.0628	CrCbGaD
Ethinyl Estradiol—Neoplasm—Doxorubicin—liver cancer	0.000312	0.00427	CcSEcCtD
Ethinyl Estradiol—Bladder pain—Doxorubicin—liver cancer	0.000312	0.00427	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Sorafenib—liver cancer	0.000311	0.00426	CcSEcCtD
Ethinyl Estradiol—Fatigue—Sorafenib—liver cancer	0.00031	0.00425	CcSEcCtD
Ethinyl Estradiol—Constipation—Sorafenib—liver cancer	0.000308	0.00422	CcSEcCtD
Ethinyl Estradiol—ESR1—liver—liver cancer	0.000303	0.00218	CbGeAlD
Ethinyl Estradiol—Eczema—Epirubicin—liver cancer	0.000301	0.00413	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Sorafenib—liver cancer	0.000294	0.00403	CcSEcCtD
Ethinyl Estradiol—Hot flush—Epirubicin—liver cancer	0.000289	0.00396	CcSEcCtD
Ethinyl Estradiol—Increased appetite—Epirubicin—liver cancer	0.000288	0.00395	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Epirubicin—liver cancer	0.000287	0.00393	CcSEcCtD
Ethinyl Estradiol—Urticaria—Sorafenib—liver cancer	0.000286	0.00392	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Sorafenib—liver cancer	0.000284	0.0039	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Sorafenib—liver cancer	0.000284	0.0039	CcSEcCtD
Ethinyl Estradiol—Eczema—Doxorubicin—liver cancer	0.000279	0.00382	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Epirubicin—liver cancer	0.000276	0.00378	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Epirubicin—liver cancer	0.000271	0.00371	CcSEcCtD
Ethinyl Estradiol—Hot flush—Doxorubicin—liver cancer	0.000268	0.00367	CcSEcCtD
Ethinyl Estradiol—Levonorgestrel—ESR1—liver cancer	0.000267	0.0532	CrCbGaD
Ethinyl Estradiol—Increased appetite—Doxorubicin—liver cancer	0.000266	0.00365	CcSEcCtD
Ethinyl Estradiol—Affect lability—Epirubicin—liver cancer	0.000266	0.00365	CcSEcCtD
Ethinyl Estradiol—Migraine—Epirubicin—liver cancer	0.000266	0.00365	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Doxorubicin—liver cancer	0.000265	0.00364	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Sorafenib—liver cancer	0.000265	0.00363	CcSEcCtD
Ethinyl Estradiol—ABCB1—embryo—liver cancer	0.000259	0.00186	CbGeAlD
Ethinyl Estradiol—Asthenia—Sorafenib—liver cancer	0.000258	0.00354	CcSEcCtD
Ethinyl Estradiol—Mood swings—Epirubicin—liver cancer	0.000256	0.00351	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Doxorubicin—liver cancer	0.000255	0.0035	CcSEcCtD
Ethinyl Estradiol—Pruritus—Sorafenib—liver cancer	0.000255	0.00349	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Doxorubicin—liver cancer	0.00025	0.00343	CcSEcCtD
Ethinyl Estradiol—CYP2C8—liver—liver cancer	0.000249	0.0018	CbGeAlD
Ethinyl Estradiol—Affect lability—Doxorubicin—liver cancer	0.000246	0.00338	CcSEcCtD
Ethinyl Estradiol—Migraine—Doxorubicin—liver cancer	0.000246	0.00338	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Sorafenib—liver cancer	0.000246	0.00337	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Epirubicin—liver cancer	0.000244	0.00335	CcSEcCtD
Ethinyl Estradiol—Danazol—ESR1—liver cancer	0.000243	0.0485	CrCbGaD
Ethinyl Estradiol—Dizziness—Sorafenib—liver cancer	0.000238	0.00326	CcSEcCtD
Ethinyl Estradiol—Mood swings—Doxorubicin—liver cancer	0.000237	0.00325	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Epirubicin—liver cancer	0.000235	0.00323	CcSEcCtD
Ethinyl Estradiol—Vomiting—Sorafenib—liver cancer	0.000229	0.00314	CcSEcCtD
Ethinyl Estradiol—Rash—Sorafenib—liver cancer	0.000227	0.00311	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Sorafenib—liver cancer	0.000227	0.00311	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Doxorubicin—liver cancer	0.000226	0.0031	CcSEcCtD
Ethinyl Estradiol—Headache—Sorafenib—liver cancer	0.000225	0.00309	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Epirubicin—liver cancer	0.000225	0.00308	CcSEcCtD
Ethinyl Estradiol—CYP2B6—liver—liver cancer	0.000224	0.00161	CbGeAlD
Ethinyl Estradiol—Dysuria—Epirubicin—liver cancer	0.000219	0.003	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Doxorubicin—liver cancer	0.000218	0.00299	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Epirubicin—liver cancer	0.000217	0.00298	CcSEcCtD
Ethinyl Estradiol—Pollakiuria—Epirubicin—liver cancer	0.000216	0.00296	CcSEcCtD
Ethinyl Estradiol—Nausea—Sorafenib—liver cancer	0.000214	0.00293	CcSEcCtD
Ethinyl Estradiol—Weight increased—Epirubicin—liver cancer	0.000213	0.00292	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Epirubicin—liver cancer	0.000212	0.0029	CcSEcCtD
Ethinyl Estradiol—Infestation—Epirubicin—liver cancer	0.000208	0.00286	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Epirubicin—liver cancer	0.000208	0.00286	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Doxorubicin—liver cancer	0.000208	0.00285	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Epirubicin—liver cancer	0.000204	0.0028	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Epirubicin—liver cancer	0.000203	0.00278	CcSEcCtD
Ethinyl Estradiol—Dysuria—Doxorubicin—liver cancer	0.000202	0.00277	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000201	0.00276	CcSEcCtD
Ethinyl Estradiol—Pollakiuria—Doxorubicin—liver cancer	0.0002	0.00274	CcSEcCtD
Ethinyl Estradiol—Weight increased—Doxorubicin—liver cancer	0.000197	0.0027	CcSEcCtD
Ethinyl Estradiol—Conjugated Estrogens—ESR1—liver cancer	0.000196	0.0392	CrCbGaD
Ethinyl Estradiol—Estrone—ESR1—liver cancer	0.000196	0.0391	CrCbGaD
Ethinyl Estradiol—Weight decreased—Doxorubicin—liver cancer	0.000196	0.00268	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Epirubicin—liver cancer	0.000196	0.00268	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Doxorubicin—liver cancer	0.000193	0.00264	CcSEcCtD
Ethinyl Estradiol—Infestation—Doxorubicin—liver cancer	0.000193	0.00264	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Doxorubicin—liver cancer	0.000189	0.00259	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Epirubicin—liver cancer	0.000188	0.00258	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Epirubicin—liver cancer	0.000188	0.00257	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Doxorubicin—liver cancer	0.000188	0.00257	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Epirubicin—liver cancer	0.000187	0.00257	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Epirubicin—liver cancer	0.000186	0.00255	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Epirubicin—liver cancer	0.000186	0.00255	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Epirubicin—liver cancer	0.000185	0.00253	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Epirubicin—liver cancer	0.000184	0.00252	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Epirubicin—liver cancer	0.000183	0.00251	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Doxorubicin—liver cancer	0.000181	0.00248	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Epirubicin—liver cancer	0.00018	0.00247	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Epirubicin—liver cancer	0.000177	0.00243	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Epirubicin—liver cancer	0.000175	0.0024	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Doxorubicin—liver cancer	0.000174	0.00239	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Doxorubicin—liver cancer	0.000174	0.00238	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Doxorubicin—liver cancer	0.000173	0.00237	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Doxorubicin—liver cancer	0.000172	0.00236	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Doxorubicin—liver cancer	0.000172	0.00236	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Doxorubicin—liver cancer	0.000171	0.00234	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Doxorubicin—liver cancer	0.00017	0.00233	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Epirubicin—liver cancer	0.00017	0.00233	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Doxorubicin—liver cancer	0.00017	0.00233	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Epirubicin—liver cancer	0.000169	0.00232	CcSEcCtD
Ethinyl Estradiol—CYP3A4—liver—liver cancer	0.000169	0.00122	CbGeAlD
Ethinyl Estradiol—Visual impairment—Doxorubicin—liver cancer	0.000167	0.00229	CcSEcCtD
Ethinyl Estradiol—Alopecia—Epirubicin—liver cancer	0.000165	0.00227	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Epirubicin—liver cancer	0.000164	0.00225	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Doxorubicin—liver cancer	0.000164	0.00224	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Epirubicin—liver cancer	0.000163	0.00223	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Doxorubicin—liver cancer	0.000162	0.00222	CcSEcCtD
Ethinyl Estradiol—Estrone—CYP2E1—liver cancer	0.000159	0.0317	CrCbGaD
Ethinyl Estradiol—Back pain—Epirubicin—liver cancer	0.000158	0.00216	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Doxorubicin—liver cancer	0.000157	0.00215	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Epirubicin—liver cancer	0.000157	0.00215	CcSEcCtD
Ethinyl Estradiol—Estrone—CYP1A1—liver cancer	0.000157	0.0312	CrCbGaD
Ethinyl Estradiol—Immune system disorder—Doxorubicin—liver cancer	0.000156	0.00214	CcSEcCtD
Ethinyl Estradiol—Alopecia—Doxorubicin—liver cancer	0.000153	0.0021	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Doxorubicin—liver cancer	0.000152	0.00208	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Epirubicin—liver cancer	0.000151	0.00207	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Doxorubicin—liver cancer	0.000151	0.00207	CcSEcCtD
Ethinyl Estradiol—Estradiol—ESR1—liver cancer	0.000148	0.0296	CrCbGaD
Ethinyl Estradiol—Malaise—Epirubicin—liver cancer	0.000147	0.00201	CcSEcCtD
Ethinyl Estradiol—Back pain—Doxorubicin—liver cancer	0.000146	0.002	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Doxorubicin—liver cancer	0.000145	0.00199	CcSEcCtD
Ethinyl Estradiol—Cough—Epirubicin—liver cancer	0.000142	0.00195	CcSEcCtD
Ethinyl Estradiol—Estropipate—ALB—liver cancer	0.00014	0.028	CrCbGaD
Ethinyl Estradiol—Ill-defined disorder—Doxorubicin—liver cancer	0.00014	0.00192	CcSEcCtD
Ethinyl Estradiol—Anxiety—Epirubicin—liver cancer	0.000138	0.00189	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000138	0.00189	CcSEcCtD
Ethinyl Estradiol—Discomfort—Epirubicin—liver cancer	0.000137	0.00188	CcSEcCtD
Ethinyl Estradiol—Malaise—Doxorubicin—liver cancer	0.000136	0.00186	CcSEcCtD
Ethinyl Estradiol—Oedema—Epirubicin—liver cancer	0.000133	0.00182	CcSEcCtD
Ethinyl Estradiol—Infection—Epirubicin—liver cancer	0.000132	0.00181	CcSEcCtD
Ethinyl Estradiol—Cough—Doxorubicin—liver cancer	0.000132	0.0018	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Epirubicin—liver cancer	0.00013	0.00179	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Epirubicin—liver cancer	0.000129	0.00177	CcSEcCtD
Ethinyl Estradiol—Anxiety—Doxorubicin—liver cancer	0.000128	0.00175	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000127	0.00175	CcSEcCtD
Ethinyl Estradiol—Discomfort—Doxorubicin—liver cancer	0.000127	0.00174	CcSEcCtD
Ethinyl Estradiol—Oedema—Doxorubicin—liver cancer	0.000123	0.00169	CcSEcCtD
Ethinyl Estradiol—Infection—Doxorubicin—liver cancer	0.000122	0.00168	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Doxorubicin—liver cancer	0.000121	0.00165	CcSEcCtD
Ethinyl Estradiol—ABCB1—liver—liver cancer	0.00012	0.000863	CbGeAlD
Ethinyl Estradiol—Skin disorder—Doxorubicin—liver cancer	0.00012	0.00164	CcSEcCtD
Ethinyl Estradiol—Estradiol—CYP1A1—liver cancer	0.000119	0.0237	CrCbGaD
Ethinyl Estradiol—Gastrointestinal disorder—Epirubicin—liver cancer	0.000115	0.00157	CcSEcCtD
Ethinyl Estradiol—Fatigue—Epirubicin—liver cancer	0.000115	0.00157	CcSEcCtD
Ethinyl Estradiol—Constipation—Epirubicin—liver cancer	0.000114	0.00156	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Epirubicin—liver cancer	0.00011	0.0015	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Epirubicin—liver cancer	0.000109	0.00149	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000106	0.00146	CcSEcCtD
Ethinyl Estradiol—Fatigue—Doxorubicin—liver cancer	0.000106	0.00145	CcSEcCtD
Ethinyl Estradiol—Urticaria—Epirubicin—liver cancer	0.000106	0.00145	CcSEcCtD
Ethinyl Estradiol—Constipation—Doxorubicin—liver cancer	0.000105	0.00144	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Epirubicin—liver cancer	0.000105	0.00144	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Epirubicin—liver cancer	0.000105	0.00144	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Doxorubicin—liver cancer	0.000101	0.00139	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Doxorubicin—liver cancer	0.000101	0.00138	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Epirubicin—liver cancer	9.8e-05	0.00134	CcSEcCtD
Ethinyl Estradiol—Urticaria—Doxorubicin—liver cancer	9.77e-05	0.00134	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Doxorubicin—liver cancer	9.73e-05	0.00133	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Doxorubicin—liver cancer	9.73e-05	0.00133	CcSEcCtD
Ethinyl Estradiol—Norethindrone—ALB—liver cancer	9.62e-05	0.0192	CrCbGaD
Ethinyl Estradiol—Asthenia—Epirubicin—liver cancer	9.54e-05	0.00131	CcSEcCtD
Ethinyl Estradiol—Pruritus—Epirubicin—liver cancer	9.41e-05	0.00129	CcSEcCtD
Ethinyl Estradiol—Methyltestosterone—ALB—liver cancer	9.14e-05	0.0182	CrCbGaD
Ethinyl Estradiol—Diarrhoea—Epirubicin—liver cancer	9.1e-05	0.00125	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Doxorubicin—liver cancer	9.07e-05	0.00124	CcSEcCtD
Ethinyl Estradiol—Asthenia—Doxorubicin—liver cancer	8.83e-05	0.00121	CcSEcCtD
Ethinyl Estradiol—Dizziness—Epirubicin—liver cancer	8.79e-05	0.00121	CcSEcCtD
Ethinyl Estradiol—Estrone—ALB—liver cancer	8.72e-05	0.0174	CrCbGaD
Ethinyl Estradiol—Pruritus—Doxorubicin—liver cancer	8.71e-05	0.00119	CcSEcCtD
Ethinyl Estradiol—Vomiting—Epirubicin—liver cancer	8.45e-05	0.00116	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Doxorubicin—liver cancer	8.42e-05	0.00115	CcSEcCtD
Ethinyl Estradiol—Rash—Epirubicin—liver cancer	8.38e-05	0.00115	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Epirubicin—liver cancer	8.38e-05	0.00115	CcSEcCtD
Ethinyl Estradiol—Headache—Epirubicin—liver cancer	8.33e-05	0.00114	CcSEcCtD
Ethinyl Estradiol—Dizziness—Doxorubicin—liver cancer	8.14e-05	0.00112	CcSEcCtD
Ethinyl Estradiol—Nausea—Epirubicin—liver cancer	7.9e-05	0.00108	CcSEcCtD
Ethinyl Estradiol—Vomiting—Doxorubicin—liver cancer	7.82e-05	0.00107	CcSEcCtD
Ethinyl Estradiol—Rash—Doxorubicin—liver cancer	7.76e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Doxorubicin—liver cancer	7.75e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Headache—Doxorubicin—liver cancer	7.71e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Nausea—Doxorubicin—liver cancer	7.31e-05	0.001	CcSEcCtD
Ethinyl Estradiol—Estradiol—ALB—liver cancer	6.61e-05	0.0132	CrCbGaD
Ethinyl Estradiol—AOX1—Disease—PIK3CD—liver cancer	1.67e-05	0.000148	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—SERPINE1—liver cancer	1.65e-05	0.000146	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	1.64e-05	0.000146	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.64e-05	0.000145	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—SERPINE1—liver cancer	1.63e-05	0.000145	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PIK3CD—liver cancer	1.62e-05	0.000144	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCR4—liver cancer	1.61e-05	0.000143	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—ALB—liver cancer	1.6e-05	0.000142	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—GSTP1—liver cancer	1.59e-05	0.000142	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PIK3CG—liver cancer	1.59e-05	0.000141	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—HMOX1—liver cancer	1.57e-05	0.00014	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GSTA4—liver cancer	1.55e-05	0.000137	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—ALB—liver cancer	1.53e-05	0.000136	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PPARG—liver cancer	1.53e-05	0.000136	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CPT1B—liver cancer	1.51e-05	0.000134	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GLUL—liver cancer	1.51e-05	0.000134	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.51e-05	0.000134	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GSTA2—liver cancer	1.51e-05	0.000134	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	1.5e-05	0.000134	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—RAF1—liver cancer	1.49e-05	0.000132	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	1.47e-05	0.000131	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—MYC—liver cancer	1.47e-05	0.00013	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—GSTM1—liver cancer	1.47e-05	0.00013	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—NR1H4—liver cancer	1.46e-05	0.000129	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GSTA1—liver cancer	1.45e-05	0.000129	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PIK3CB—liver cancer	1.45e-05	0.000129	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MTOR—liver cancer	1.45e-05	0.000129	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—NAT2—liver cancer	1.44e-05	0.000128	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	1.43e-05	0.000127	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	1.43e-05	0.000127	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTA3—liver cancer	1.43e-05	0.000127	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	1.42e-05	0.000126	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PIK3CB—liver cancer	1.41e-05	0.000126	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PIK3CD—liver cancer	1.4e-05	0.000124	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—CYP1A1—liver cancer	1.39e-05	0.000123	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	1.39e-05	0.000123	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—RAF1—liver cancer	1.39e-05	0.000123	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	1.38e-05	0.000123	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ALDOB—liver cancer	1.38e-05	0.000122	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—ALB—liver cancer	1.38e-05	0.000122	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CDKN1B—liver cancer	1.36e-05	0.000121	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	1.35e-05	0.00012	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—UGDH—liver cancer	1.34e-05	0.000119	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GLUL—liver cancer	1.32e-05	0.000117	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CPT1B—liver cancer	1.32e-05	0.000117	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CRABP1—liver cancer	1.31e-05	0.000117	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTA4—liver cancer	1.31e-05	0.000116	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—MTHFR—liver cancer	1.3e-05	0.000115	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CTNNB1—liver cancer	1.29e-05	0.000114	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.28e-05	0.000114	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTA2—liver cancer	1.28e-05	0.000113	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PPARA—liver cancer	1.27e-05	0.000113	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—ADAM17—liver cancer	1.27e-05	0.000113	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—NR1H4—liver cancer	1.27e-05	0.000113	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CDKN1A—liver cancer	1.26e-05	0.000112	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—EPT1—liver cancer	1.26e-05	0.000112	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	1.25e-05	0.000111	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTA3—liver cancer	1.25e-05	0.000111	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—H2AFX—liver cancer	1.24e-05	0.00011	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTA1—liver cancer	1.23e-05	0.000109	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—NAT2—liver cancer	1.22e-05	0.000108	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PIK3CB—liver cancer	1.22e-05	0.000108	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	1.2e-05	0.000107	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PSMD10—liver cancer	1.19e-05	0.000106	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PSMA4—liver cancer	1.19e-05	0.000106	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—TAT—liver cancer	1.19e-05	0.000106	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.17e-05	0.000104	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ALDOB—liver cancer	1.17e-05	0.000104	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	1.15e-05	0.000102	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—HPGDS—liver cancer	1.15e-05	0.000102	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	1.15e-05	0.000102	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.14e-05	0.000101	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTA4—liver cancer	1.14e-05	0.000101	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—STAT3—liver cancer	1.12e-05	9.97e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CRABP1—liver cancer	1.11e-05	9.89e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTA2—liver cancer	1.11e-05	9.87e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PPARA—liver cancer	1.1e-05	9.8e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PIK3CG—liver cancer	1.09e-05	9.67e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—MYC—liver cancer	1.08e-05	9.6e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTA1—liver cancer	1.07e-05	9.53e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	1.07e-05	9.52e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	1.06e-05	9.44e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—NAT2—liver cancer	1.06e-05	9.42e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PPARG—liver cancer	1.05e-05	9.33e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MYC—liver cancer	1.04e-05	9.27e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—TGFB1—liver cancer	1.04e-05	9.24e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—MYC—liver cancer	1.03e-05	9.16e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PSMA4—liver cancer	1.02e-05	9.1e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PSMD10—liver cancer	1.02e-05	9.1e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—MAPK14—liver cancer	1.02e-05	9.05e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ALDOB—liver cancer	1.02e-05	9.03e-05	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—AKT1—liver cancer	1.02e-05	9.03e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1e-05	8.9e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GOT2—liver cancer	9.96e-06	8.85e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	9.77e-06	8.68e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—HPGDS—liver cancer	9.73e-06	8.64e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CRABP1—liver cancer	9.7e-06	8.61e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	9.69e-06	8.61e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.67e-06	8.59e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—KRAS—liver cancer	9.64e-06	8.56e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PIK3CD—liver cancer	9.57e-06	8.5e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	9.45e-06	8.39e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ALB—liver cancer	9.44e-06	8.39e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYP2E1—liver cancer	9.37e-06	8.32e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PRKCE—liver cancer	9.25e-06	8.22e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PPARG—liver cancer	9.12e-06	8.1e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PIK3CA—liver cancer	8.85e-06	7.87e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.81e-06	7.83e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYCS—liver cancer	8.77e-06	7.79e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IGF2—liver cancer	8.76e-06	7.79e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.7e-06	7.73e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PSMA4—liver cancer	8.67e-06	7.7e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PSMD10—liver cancer	8.67e-06	7.7e-05	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PIK3CA—liver cancer	8.62e-06	7.66e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GGT1—liver cancer	8.6e-06	7.64e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GOT1—liver cancer	8.6e-06	7.64e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—HPGDS—liver cancer	8.48e-06	7.53e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GOT2—liver cancer	8.44e-06	7.49e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PIK3CB—liver cancer	8.34e-06	7.41e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—SERPINE1—liver cancer	8.22e-06	7.3e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—HRAS—liver cancer	8.19e-06	7.28e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CSF2—liver cancer	8.18e-06	7.27e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CPT1B—liver cancer	8.1e-06	7.2e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GLUL—liver cancer	8.1e-06	7.2e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—H2AFX—liver cancer	8.07e-06	7.16e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	7.98e-06	7.09e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYP2E1—liver cancer	7.93e-06	7.05e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—IL6—liver cancer	7.84e-06	6.97e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—NR1H4—liver cancer	7.81e-06	6.94e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GSTP1—liver cancer	7.73e-06	6.86e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTA3—liver cancer	7.68e-06	6.82e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.68e-06	6.82e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—HMOX1—liver cancer	7.62e-06	6.77e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PSMA4—liver cancer	7.56e-06	6.71e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PSMD10—liver cancer	7.56e-06	6.71e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYCS—liver cancer	7.42e-06	6.59e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PIK3CA—liver cancer	7.42e-06	6.59e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GOT2—liver cancer	7.35e-06	6.53e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TERT—liver cancer	7.29e-06	6.48e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GOT1—liver cancer	7.28e-06	6.47e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GGT1—liver cancer	7.28e-06	6.47e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—AKT1—liver cancer	7.23e-06	6.43e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	7.21e-06	6.4e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—AKT1—liver cancer	7.15e-06	6.35e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GSTM1—liver cancer	7.1e-06	6.31e-05	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—AKT1—liver cancer	7.04e-06	6.26e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTA4—liver cancer	7.03e-06	6.24e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP2E1—liver cancer	6.91e-06	6.14e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTA2—liver cancer	6.85e-06	6.08e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYP1A1—liver cancer	6.73e-06	5.98e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KDR—liver cancer	6.67e-06	5.93e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MAPK14—liver cancer	6.63e-06	5.89e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTA1—liver cancer	6.61e-06	5.87e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTP1—liver cancer	6.54e-06	5.81e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—NAT2—liver cancer	6.53e-06	5.8e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	6.52e-06	5.79e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYCS—liver cancer	6.47e-06	5.74e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—HMOX1—liver cancer	6.45e-06	5.73e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—F2—liver cancer	6.42e-06	5.7e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GGT1—liver cancer	6.34e-06	5.64e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GOT1—liver cancer	6.34e-06	5.64e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—MTHFR—liver cancer	6.28e-06	5.57e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ALDOB—liver cancer	6.26e-06	5.56e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PPARA—liver cancer	6.16e-06	5.47e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PIK3CG—liver cancer	6.15e-06	5.46e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—APC—liver cancer	6.15e-06	5.46e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—AKT1—liver cancer	6.06e-06	5.38e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTM1—liver cancer	6.01e-06	5.34e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CRABP1—liver cancer	5.97e-06	5.31e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—BRAF—liver cancer	5.78e-06	5.13e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTP1—liver cancer	5.7e-06	5.06e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYP1A1—liver cancer	5.7e-06	5.06e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—HMOX1—liver cancer	5.62e-06	4.99e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PIK3CD—liver cancer	5.4e-06	4.8e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SERPINE1—liver cancer	5.34e-06	4.75e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—MTHFR—liver cancer	5.31e-06	4.72e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PIK3CG—liver cancer	5.27e-06	4.68e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTM1—liver cancer	5.24e-06	4.65e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—HPGDS—liver cancer	5.22e-06	4.64e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PPARA—liver cancer	5.21e-06	4.63e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—MYC—liver cancer	5.2e-06	4.62e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PPARG—liver cancer	5.09e-06	4.52e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PIK3CA—liver cancer	5.08e-06	4.51e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP1A1—liver cancer	4.96e-06	4.41e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—RAF1—liver cancer	4.82e-06	4.28e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MTOR—liver cancer	4.71e-06	4.18e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PIK3CB—liver cancer	4.71e-06	4.18e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.68e-06	4.16e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PSMD10—liver cancer	4.65e-06	4.13e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PSMA4—liver cancer	4.65e-06	4.13e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PIK3CD—liver cancer	4.63e-06	4.12e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—MTHFR—liver cancer	4.63e-06	4.11e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ALB—liver cancer	4.58e-06	4.06e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PPARA—liver cancer	4.54e-06	4.03e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GOT2—liver cancer	4.53e-06	4.02e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PIK3CG—liver cancer	4.46e-06	3.96e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CDKN1B—liver cancer	4.42e-06	3.93e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CASP3—liver cancer	4.33e-06	3.85e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL2—liver cancer	4.32e-06	3.84e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PPARG—liver cancer	4.31e-06	3.83e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP2E1—liver cancer	4.26e-06	3.78e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCND1—liver cancer	4.22e-06	3.74e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—JUN—liver cancer	4.21e-06	3.74e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CTNNB1—liver cancer	4.17e-06	3.71e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—AKT1—liver cancer	4.15e-06	3.69e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MMP9—liver cancer	4.09e-06	3.64e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CDKN1A—liver cancer	4.08e-06	3.62e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PIK3CB—liver cancer	4.04e-06	3.59e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYCS—liver cancer	3.98e-06	3.54e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MAPK8—liver cancer	3.98e-06	3.54e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PIK3CD—liver cancer	3.92e-06	3.49e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GOT1—liver cancer	3.91e-06	3.47e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GGT1—liver cancer	3.91e-06	3.47e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PIK3CG—liver cancer	3.89e-06	3.45e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ALB—liver cancer	3.87e-06	3.44e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PPARG—liver cancer	3.75e-06	3.33e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—VEGFA—liver cancer	3.68e-06	3.26e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—STAT3—liver cancer	3.64e-06	3.23e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—AKT1—liver cancer	3.61e-06	3.2e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTP1—liver cancer	3.51e-06	3.12e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—HMOX1—liver cancer	3.46e-06	3.08e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PIK3CB—liver cancer	3.42e-06	3.04e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PIK3CD—liver cancer	3.42e-06	3.04e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MYC—liver cancer	3.38e-06	3e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ALB—liver cancer	3.37e-06	3e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TGFB1—liver cancer	3.37e-06	3e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTM1—liver cancer	3.23e-06	2.87e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KRAS—liver cancer	3.12e-06	2.78e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP1A1—liver cancer	3.06e-06	2.72e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PIK3CB—liver cancer	2.98e-06	2.65e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PIK3CA—liver cancer	2.87e-06	2.55e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—MTHFR—liver cancer	2.85e-06	2.53e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PPARA—liver cancer	2.8e-06	2.49e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TP53—liver cancer	2.78e-06	2.47e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—HRAS—liver cancer	2.66e-06	2.36e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL6—liver cancer	2.54e-06	2.26e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PIK3CA—liver cancer	2.46e-06	2.19e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIK3CG—liver cancer	2.4e-06	2.13e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—AKT1—liver cancer	2.35e-06	2.08e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PPARG—liver cancer	2.31e-06	2.05e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIK3CD—liver cancer	2.11e-06	1.87e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PIK3CA—liver cancer	2.08e-06	1.85e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ALB—liver cancer	2.08e-06	1.85e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—AKT1—liver cancer	2.01e-06	1.79e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIK3CB—liver cancer	1.84e-06	1.63e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PIK3CA—liver cancer	1.82e-06	1.61e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—AKT1—liver cancer	1.7e-06	1.51e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—AKT1—liver cancer	1.48e-06	1.32e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIK3CA—liver cancer	1.12e-06	9.94e-06	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—AKT1—liver cancer	9.14e-07	8.12e-06	CbGpPWpGaD
